Van Gaal LF - Search Results

1

Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and the HLA DQA1*0501-DQB1*0301 haplotype in Type 1 diabetes mellitus. Belgian Diabetes Registry.

De Block CE, De Leeuw IH, Rooman RP, Winnock F, Du Caju MV, Van Gaal LF. De Block CE, et al. Among authors: van gaal lf. Diabet Med. 2000 Aug;17(8):618-22. doi: 10.1046/j.1464-5491.2000.00354.x. Diabet Med. 2000. PMID: 11073185

2

High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 (insulin-dependent) diabetic patients. The Belgian Diabetes Registry.

De Block CE, De Leeuw IH, Van Gaal LF. De Block CE, et al. Among authors: van gaal lf. J Clin Endocrinol Metab. 1999 Nov;84(11):4062-7. doi: 10.1210/jcem.84.11.6095. J Clin Endocrinol Metab. 1999. PMID: 10566650

3

Soluble transferrin receptor level: a new marker of iron deficiency anemia, a common manifestation of gastric autoimmunity in type 1 diabetes.

De Block CE, Van Campenhout CM, De Leeuw IH, Keenoy BM, Martin M, Van Hoof V, Van Gaal LF. De Block CE, et al. Among authors: van gaal lf, van campenhout cm, van hoof v. Diabetes Care. 2000 Sep;23(9):1384-8. doi: 10.2337/diacare.23.9.1384. Diabetes Care. 2000. PMID: 10977038

4

Helicobacter pylori, parietal cell antibodies and autoimmune gastropathy in type 1 diabetes mellitus.

De Block CE, De Leeuw IH, Bogers JJ, Pelckmans PA, Ieven MM, Van Marck EA, Van Hoof V, Máday E, Van Acker KL, Van Gaal LF. De Block CE, et al. Among authors: van acker kl, van gaal lf, van hoof v, van marck ea. Aliment Pharmacol Ther. 2002 Feb;16(2):281-9. doi: 10.1046/j.1365-2036.2002.01186.x. Aliment Pharmacol Ther. 2002. PMID: 11860411

5

Upper body adiposity and the risk for atherosclerosis.

Van Gaal LF, Vansant GA, De Leeuw IH. Van Gaal LF, et al. J Am Coll Nutr. 1989 Dec;8(6):504-14. doi: 10.1080/07315724.1989.10720320. J Am Coll Nutr. 1989. PMID: 2695550 Review.

6

Autoimmune hepatitis, autoimmune gastritis, and gastric carcinoid in a type 1 diabetic patient: a case report.

De Block CE, De Leeuw IH, Pelckmans PA, Michielsen PP, Bogers JJ, Van Marck EA, Van Gaal LF. De Block CE, et al. Among authors: van gaal lf, van marck ea. J Diabetes Complications. 2000 Mar-Apr;14(2):116-20. doi: 10.1016/s1056-8727(00)00059-3. J Diabetes Complications. 2000. PMID: 10959074

7

Low-density lipoprotein receptor gene mutation analysis and clinical correlation in Belgian hypercholesterolaemics.

Van Gaal LF, Peeters AV, De Block CE, de Leeuw IH, Thiart R, Kotze MJ. Van Gaal LF, et al. Mol Cell Probes. 2001 Dec;15(6):329-36. doi: 10.1006/mcpr.2001.0378. Mol Cell Probes. 2001. PMID: 11851376

8

Rationale and options for combination therapy in the treatment of Type 2 diabetes.

Van Gaal LF, De Leeuw IH. Van Gaal LF, et al. Diabetologia. 2003 Mar;46 Suppl 1:M44-50. doi: 10.1007/s00125-002-0936-0. Epub 2003 Feb 5. Diabetologia. 2003. PMID: 12652358 Review.

9

Long term magnesium supplementation influences favourably the natural evolution of neuropathy in Mg-depleted type 1 diabetic patients (T1dm).

De Leeuw I, Engelen W, De Block C, Van Gaal L. De Leeuw I, et al. Magnes Res. 2004 Jun;17(2):109-14. Magnes Res. 2004. PMID: 15319143 Free article. Clinical Trial.

10

Factors determining energy expenditure during very-low-calorie diets.

Van Gaal LF, Vansant GA, De Leeuw IH. Van Gaal LF, et al. Am J Clin Nutr. 1992 Jul;56(1 Suppl):224S-229S. doi: 10.1093/ajcn/56.1.224S. Am J Clin Nutr. 1992. PMID: 1615888 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters